PURPOSE: A hedera helix leaf extract or a compound separated from the same are provided to utilize as a medicinal composition for prevention and treatment of an infectious diseas by an influenza virus or a health functional food by checking a high survival rate when taken together with an antivirus agent. CONSTITUTION: A medicinal composition for prevention and treatment of an infectious disease caused by an influenza virus contains a Hedera helix leaf extract or hederacoside C separated from th...

PURPOSE: A pharmaceutical composition or a health food composition containing sulfur-containing extracellular polysaccharides p-KG03 is provided to prevent and treat influenza viral infection. CONSTITUTION: A pharmaceutical composition for preventing or treating influenza virus A infection contains sulfur-containing extracelullar p-KG03 as an active ingredient isolated from Gyrodinium impudicum KG03(KCTC 10325BP). The optimal temperature and pH of extracellular polysaccharide p-KG03 is 25-30 deg...

Kits comprising an M2 inhibitor selected from amantadine and rimantadine; ribavirin and a neuraminidase inhibitor (NAi) in an amount that is antivirally effective in the combination an oral dosage form containing 75-250 mg of the M2 inhibitor an oral dosage form comprising 100-400 mg of ribavirin and a neuraminidase inhibitor are provided for the treatment of influenza. Some embodiments of the kits comprise an oral dosage form containing 75-250 mg of the M2 inhibitor an oral dosage form comprisi...

This invention concerns adamantanamines (e.g. memantine amantadine and rimantadine) and neramexane salts of thiomolybdic and thiotungstic acids including their preparation and pharmaceutical compositions as dual acting drugs. These salts are used to treat or potentially arrest the neurodegenerative pathophysiology clinical signs and symptoms of dementia of the Alzheimer's type Parkinson's Huntington's AIDS-related dementia and Schizophrenia and its cognitive deficits. Additional uses of these de...

Compositions for pharmaceutical and other uses comprising clear aqueous solutions of bile acids which do not form any detectable precipitates over selected ranges of pH values of the aqueous solution and methods of making such solutions. The compositions of the invention comprise water; a bile acid in the form of a bile acid bile acid salt or a bile acid conjugated with an amine by an amide linkage; and either or both an aqueous soluble starch conversion product and a aqueous soluble non-starch ...